Examkin

Soru

Zorluk: ZorPreventive Care and Immunizations

A 4-year-old girl is brought to the pediatric clinic for a routine well-child visit. She has a history of perinatally acquired HIV infection. Her mother admits they have struggled with adherence to her antiretroviral therapy regimen over the past year. Her most recent laboratory studies from two weeks ago show an HIV viral load of 150,000 copies/mL and a CD4 T-lymphocyte count of 250 cells/mm³ (CD4 percentage of 11%). She recently recovered from a mild upper respiratory tract infection but has no symptoms today. Vital signs are within normal limits for her age. Review of her immunization record indicates she received all age-appropriate vaccines during infancy and toddlerhood, but she is currently due for her 4-year preschool boosters. During the physical examination, the girl is observed hopping on one foot and successfully copying a cross drawn by the physician. Her mother notes that she frequently engages in cooperative play with other children at daycare. Which of the following is the most appropriate plan for this patient today?

  1. A
    Administer DTaP, IPV, MMR, and varicella vaccines; development is age-appropriate
  2. B
    Defer all immunizations until the patient's HIV viral load becomes undetectable; development is age-appropriate
  3. Administer DTaP and IPV, but withhold MMR and varicella vaccines; development is age-appropriateCevap
  4. D
    Administer DTaP and IPV, but withhold MMR and varicella vaccines; refer for neurodevelopmental evaluation due to gross motor delay
  5. E
    Administer DTaP, IPV, MMR, and varicella vaccines; refer for neurodevelopmental evaluation due to fine motor delay

Cevap

Administer DTaP and IPV, but withhold MMR and varicella vaccines; development is age-appropriate
The correct approach involves accurately assessing both the patient's developmental milestones and her immunization eligibility given her HIV status. For a 4-year-old child, normal developmental milestones include hopping on one foot (gross motor), copying a cross (fine motor), and engaging in cooperative play (social). Because this patient exhibits these skills, her development is completely age-appropriate, and no neurodevelopmental referral is indicated. Regarding immunizations, children at age 4 are due for their preschool boosters: DTaP, IPV, MMR, and varicella. While inactivated vaccines (such as DTaP and IPV) are safe and recommended for all HIV-infected children regardless of their immune status, live-attenuated vaccines (MMR, varicella) carry a severe risk of disseminated infection in immunocompromised hosts. According to CDC guidelines, severe immunosuppression in children aged 1 to 5 years is defined as a CD4 count <500 cells/mm³ or a CD4 percentage <15%. This patient's CD4 count of 250 cells/mm³ and CD4% of 11% firmly place her in the severely immunosuppressed category, making the live-attenuated MMR and varicella vaccines strictly contraindicated today.

Adım Adım Çözüm

1
Evaluate the patient's developmental milestones based on the physical exam findings.
Hopping on one foot (gross motor), copying a cross (fine motor), and playing cooperatively (social) are all normal, age-appropriate milestones for a 4-year-old child.
To determine if a neurodevelopmental referral is indicated or if the parents can be reassured.
2
Identify the routine immunizations due for a 4-year-old child.
The standard preschool booster vaccines required at age 4 include DTaP, IPV, MMR, and varicella.
To establish the baseline immunization needs before applying patient-specific contraindications.
3
Assess the patient's immune status based on her age and HIV laboratory results.
For a child aged 1 to 5 years, a CD4 count <500 cells/mm³ or a CD4 percentage <15% defines severe immunosuppression. The patient's CD4 count of 250 cells/mm³ (11%) meets these criteria.
To determine if live-attenuated vaccines are safe to administer.
4
Synthesize findings to formulate the final management plan.
Inactivated vaccines (DTaP, IPV) are safe and must be administered. Live-attenuated vaccines (MMR, varicella) are absolutely contraindicated due to severe immunosuppression. No developmental referral is needed.
This provides optimal disease protection without risking disseminated vaccine-strain infection, while correctly addressing developmental progress.

Anahtar Kavram

Live-attenuated vaccines (MMR, Varicella) are contraindicated in HIV-infected children aged 1-5 years with severe immunosuppression, defined as a CD4 count <500 cells/mm³ or CD4 <15%.
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru